Troy Chen

Troy Chen, CFA, is a seasoned investment professional with extensive experience in the healthcare sector. Currently serving as Managing Director at Hillhouse since 2020, Troy specializes in growth and buyout investments in China's healthcare space. Prior to this role, Troy was Director of the Healthcare Fund at China Renaissance from 2018 to 2020, focusing on significant minority and mid-market buyouts in the medtech sector. Troy's career also includes positions as Principal at Actis, where attention was given to significant minority and mid-market buyouts within the healthcare team, and as an Associate in the Investment Banking Division at Morgan Stanley, emphasizing IPOs, M&A, and debt in healthcare and real estate. Early career experience at Boston Consulting Group involved business strategy and commercial due diligence in various sectors, including financial services and technology. Troy Chen holds an MBA from Columbia Business School and a Bachelor's degree in Economics with a focus on Finance from Peking University.